1-9 of 9
Lucia Ahlberg
Close
Sort by
Journal Articles

A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

Raija Helena Silvennoinen, MDPhD, Anders Waage, MD PhD, Valdas Peceliunas, MD, Fredrik Schjesvold, MDPhD, Pekka Anttila, MD, Marjaana Säily, MD PhD, Mervi Putkonen, MD PhD, Kristina Carlson, MD, Einar Haukaas, MD, Marja Sankelo, MDPhD, Anu Partanen, MD PhD, Damian L. Szatkowski, MDPhDMSc, Markus Hansson, MD PhD, Anu Marttila, MD, Lucia Ahlberg, MD, Per Axelsson, MD, Birgitta Lauri, MD, Maija Helena Mikkola, MD, Conny Karlsson, MD, Johanna Abelsson, MD, Erik Ahlstrand, MD PhD, Anu Sikiö, MD, Monika Klimkowska, MD PhD, Reda Matuzeviciene, MD PhD, Mona Hoysaeter Fenstad, MD PhD, Sorella Ilveskero, MD PhD, Hareth Nahi, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-138643
Published: 2020
Journal Articles

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex

Johan Lund, MD, Sigrid Karstorp, MD, Evren Alici, MD PhD, Astrid Gruber, MD PhD, Birgitta Lauri, MD, Cecilie Blimark, MD PhD, Agneta Swedin, MD PhD, Markus Hansson, MD PhD, Karin Forsberg, MD, Lucia Ahlberg, MD, Carlsson Conny, MD, Anders Waage, MD PhD, Peter Gimsing, Annette Juul Vangsted, MD PhD, Ulf Christian Frølund, MD, Mats Hardling, Ulf-Henrik Mellqvist, MD PhD, Hareth Nahi
Journal: Blood
Blood (2015) 126 (23): 3047.
https://doi.org/10.1182/blood.V126.23.3047.3047
Published: 2015
Journal Articles

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Cecilie Blimark, MD, Erik Holmberg, PhD, Gunnar Juliusson, MD, PhD, Hareth Nahi, MD, PhD, Forsberg Karin, MD, PhD, Ingemar Turesson, MD, PhD, Lucia Ahlberg, MD., PhD., Ronald Svensson, MD, Olle Linder, MD, Kristina Carlsson, MD, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1972.
https://doi.org/10.1182/blood.V122.21.1972.1972
Published: 2013
Journal Articles

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Clinical Trials & Observations
Ulf-Henrik Mellqvist, Peter Gimsing, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Cecilie Blimark, Inger Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukås, Kristina Carlson, Ann Kristin Kvam, Hareth Nahi, Roald Lindås, Niels Frost Andersen, Ingemar Turesson, Anders Waage, Jan Westin
Journal: Blood
Blood (2013) 121 (23): 4647–4654.
https://doi.org/10.1182/blood-2012-11-464503
Published: 2013
Journal Articles

Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study

Meletios A. Dimopoulos, Hadewijch M De Samblanx, MD, Maria G Roussou, Konstantinos Zervas, Eirini Katodritou, Deniz Sargin, MD, Cyrille Hulin, MD, Lucia Ahlberg, MD, Javier De La Rubia, Rita Ganguly, PhD, Joris K Diels, MSc, Helgi van de Velde, MD, PhD, Ravinder Dhawan, PhD, Michael D Spencer, MSc, Michel Delforge, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3027.
https://doi.org/10.1182/blood.V116.21.3027.3027
Published: 2010
Journal Articles

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Clinical Trials & Observations
Anders Waage, Peter Gimsing, Peter Fayers, Niels Abildgaard, Lucia Ahlberg, Bo Björkstrand, Kristina Carlson, Inger Marie Dahl, Karin Forsberg, Nina Gulbrandsen, Einar Haukås, Øyvind Hjertner, Martin Hjorth, Torbjörn Karlsson, Lene Meldgaard Knudsen, Johan Lanng Nielsen, Olle Linder, Ulf-Henrik Mellqvist, Ingerid Nesthus, Jürgen Rolke, Maria Strandberg, Jon Hjalmar Sørbø, Finn Wisløff, Gunnar Juliusson, Ingemar Turesson, for the Nordic Myeloma Study Group
Journal: Blood
Blood (2010) 116 (9): 1405–1412.
https://doi.org/10.1182/blood-2009-08-237974
Published: 2010
Journal Articles

Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial.

Ulf-Henrik Mellqvist, MD, PhD, Jan Westin, MD, PhD, Peter Gimsing, DO, PhD, Oyvind Hjertner, Stig Lenhoff, MD, PhD, Edward Laane, Kari Remes, MD, PhD, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Kristina Carlsson, Inge Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, MD, PhD, Henrik Gregersen, Astrid Gruber, MD, PhD, Nina Guldbrandsen, Einar Haukås, Olle Linder, Hareth Nahi, Ingerid Nesthus, Nilsaage Toffner-Clausen, Raija Silvennoinen, Niels Frost Andersen, MD, Ingemar Turesson, MD, PhD, Anders Waage, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 530.
https://doi.org/10.1182/blood.V114.22.530.530
Published: 2009
Journal Articles

Characterization of Patients with Multiple Myeloma Achieving Complete Response to Bortezomib: An Interim Report From An International Electronic Observational Study.

Michel Delforge, MD, PhD, Hadewijch De Samblanx, Maria Roussou, Konstantinos Zervas, Eirini Katodritou, Kudrat M Abdulkadyrov, Deniz Sargin, Cyrille Hulin, Lucia Ahlberg, Javier de la Rubia, Rita Ganguly, Joris Diels, Ravinder Dhawan, Meletios A. Dimopoulos
Journal: Blood
Blood (2009) 114 (22): 4938.
https://doi.org/10.1182/blood.V114.22.4938.4938
Published: 2009
Journal Articles

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT

Clinical Trials & Observations
Charles Crawley, Marc Lalancette, Richard Szydlo, Maria Gilleece, Karl Peggs, Stephen Mackinnon, Gunnar Juliusson, Lucia Ahlberg, Arnon Nagler, Avichai Shimoni, Anna Sureda, Jean-Michel Boiron, Herman Einsele, Rajesh Chopra, Angelo Carella, Jamie Cavenagh, Alois Gratwohl, Frederic Garban, Axel Zander, Bo Björkstrand, Dietger Niederwieser, Gösta Gahrton, Jane F. Apperley, for the Chronic Leukaemia Working Party of the EBMT
Journal: Blood
Blood (2005) 105 (11): 4532–4539.
https://doi.org/10.1182/blood-2004-06-2387
Published: 2005